Skip to main content
. 2014 Jan 28;20(4):1061–1066. doi: 10.3748/wjg.v20.i4.1061

Figure 1.

Figure 1

Flow of the study. A total of 1197 patients were investigated in the study period, and 573 patients in Group A [without proton pump inhibitors (PPI) pretreatment] and 517 in Group B (with PPI pretreatment) were included in the analysis. Patients in Group B were reclassified into three groups based on the duration of PPI pretreatment: Group B-1 (3-14 d), Group B-2 (15-55 d) and Group B-3 (≥ 56 d). H2RA: H2 receptor antagonist.